Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Biol Sci 2020; 16(14):2518-2526. doi:10.7150/ijbs.48330 This issue Cite

Review

Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives

Ting Gan, Yang Li, Xu-jie Zhou✉, Hong Zhang

Renal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, 100034, People's Republic of China; Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences.

✉ Corresponding author: Dr. Xu-jie Zhou, MD & PhD. E-mail: zhouxujieedu.cn; Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China; Key Labora More

Citation:
Gan T, Li Y, Zhou Xj, Zhang H. Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives. Int J Biol Sci 2020; 16(14):2518-2526. doi:10.7150/ijbs.48330. https://www.ijbs.com/v16p2518.htm
Other styles

File import instruction

Abstract

Graphic abstract

IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and renal failure. The exact pathogenesis of IgAN is not well defined, but some genetic studies have led to a novel discovery that the immunoproteasome probably plays an important role in IgAN. The immunoproteasome is a proteasome variant that is expressed when cells are stressed or receive inflammatory signals. While immunoproteasome is suggested to be mainly involved in major histocompatibility complex-I (MHC-I) antigen presentation, recent studies indicate that it may assert broad functions in trafficking events that activate both innate and adaptive immunity. In this review, we first summarize new insights into its functions in immunity, and discuss how it underlies its associations with IgAN. We also highlight its potential as a therapeutic target for the future.

Keywords: IgA nephropathy, Glomerulonephritis, Immunoproteasome, Autoimmunity

Citation styles

APA
Gan, T., Li, Y., Zhou, X.j., Zhang, H. (2020). Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives. International Journal of Biological Sciences, 16(14), 2518-2526. https://doi.org/10.7150/ijbs.48330.

ACS
Gan, T.; Li, Y.; Zhou, X.j.; Zhang, H. Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives. Int. J. Biol. Sci. 2020, 16 (14), 2518-2526. DOI: 10.7150/ijbs.48330.

NLM
Gan T, Li Y, Zhou Xj, Zhang H. Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives. Int J Biol Sci 2020; 16(14):2518-2526. doi:10.7150/ijbs.48330. https://www.ijbs.com/v16p2518.htm

CSE
Gan T, Li Y, Zhou Xj, Zhang H. 2020. Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives. Int J Biol Sci. 16(14):2518-2526.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use